|
Sagent Pharma launches colistimethate for injection, USP
|
|
Schaumburg, Illinois
December 29 , 2014
|
|
|
Sagent Pharmaceuticals, a specialty pharmaceutical company focussed on
developing, manufacturing, sourcing and marketing pharmaceutical
products ,announced the launch of Colistimethate for injection, USP, an
anti-infective, in a preservative-free glass vial.
According to
IMS, for the 12 months ending October 2014, the US market for
Colistimethate approximated $12 million. As with all products in
Sagent's portfolio, Colistimethate features Sagent's PreventIV Measures
SM packaging and labelling, designed to help reduce medication errors.
Colistimethate
for injection, USP is indicated for the treatment of acute or chronic
infections due to sensitive strains of certain gram-negative bacilli. It
is particularly indicated when the infection is caused by sensitive
strains of Pseudomonas aeruginosa.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|